Buprenorphine for Late-Life Treatment Resistant Depression.

Trial Profile

Buprenorphine for Late-Life Treatment Resistant Depression.

Phase of Trial: Phase II

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Buprenorphine (Primary)
  • Indications Major depressive disorder
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms BUILD
  • Most Recent Events

    • 26 Jun 2012 Actual patient number 15 added as reported by ClinicalTrials.gov.
    • 26 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Jun 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top